Cooperative Agreement NU2GGH002378

This Cooperative Agreement award, funded by the U.S. Department of Health and Human Services' Centers for Disease Control and Prevention under the Global AIDS Federal Grant Program (CFDA 93.067), provides $6,300,000 over 5 years to the South African National AIDS Council Trust (SANAC Trust) to support multi-sectoral coordination, management, monitoring, and community engagement for the national HIV/AIDS response in South Africa. The award aims to strengthen the SANAC Trust's capacity to lead...

This $780,447 federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), supports a study titled "The SUSTAIN 2 Study - Sustained HIV Treatment for Adherence After Interruption in Care" in South Africa. The award to Brigham & Women's Hospital Inc. will fund a hybrid clinical trial to evaluate the effectiveness of a differentiated service delivery model (CARES-DSD) in improving viral suppression...

This $5,900,000 Cooperative Agreement award, funded by the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067), supports the National Health Laboratory Service (NHLS) in South Africa to conduct a range of activities focused on infectious disease surveillance, detection, and response. Key products and services delivered through this award include: Establishing case surveillance systems using electronic records to monitor HIV drug resistance; disease...

This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) provides $6,082,948 in funding to (Hisp) Health Information Systems Program South Africa, a non-profit organization, to deliver technical assistance and support for strengthening the Government of Lesotho's national and district HIV and TB programming. The 5-year award (9/30/2024 - 9/30/2029) will support activities focused on developing and...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research program) provides $582,959 over 3 years to The Johns Hopkins University to integrate a "Universal Test-and-Connect" (UTC) strategy to deliver HIV preventative and therapeutic services in high-volume emergency department (ED) settings in Cape Town, South Africa. The key products and services to be delivered under this award include: 1)...

The South African Medical Research Council (MRC) was awarded a $4,968,390.00 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Global AIDS (CFDA 93.067) federal grant program. The award period runs from September 30, 2024 to September 29, 2029. The purpose of this Cooperative Agreement is to strengthen strategic health information systems and support public health initiatives focused on HIV/AIDS, tuberculosis, and other infectious diseases in South...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $546,966 to Stellenbosch University in South Africa for the "African Tuberculosis Bioinformatics Training Program." The program aims to: Implement a new structured bioinformatics MSc curriculum with a strong research training component, including tuberculosis (TB) biology modules. Train students in responsible, rigorous...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $873,784 to Arizona State University to develop, pilot, and evaluate an intervention called Project Vuselela (PV) that integrates peer navigation and family engagement to improve antiretroviral therapy (ART) adherence and opioid substitution therapy (OST) continuation among people who inject drugs living with HIV in South Africa. The key...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $271,004 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the South African Medical Research Council (MRC), a non-profit research organization, to investigate new 6-month treatment regimens for rifampicin-resistant tuberculosis (RR-TB) in pregnant and postpartum women. The key objectives are to: Assess adherence to RR-TB treatment and associated factors like depression in...

The Department of State Bureau of African Affairs awarded a $110,000 project grant to Treatment Advocacy And Litera CY Campaign to implement the COMMUNITY LED MONITORING TO IMPROVE QUALITY OF HIV CARE IN ZAMBIA THROUGH CLIENT FEEDBACK project from March 1, 2022 to December 30, 2022. Under this award, Treatment Advocacy And Litera CY Campaign will work to improve HIV care quality in Zambia by establishing a community-led monitoring program that gathers client feedback. The grant is part of the...